(Press-News.org) University of Pittsburgh and University of California, Irvine (UCI) researchers have received funding from the National Institute of Aging to advance understanding of real-world patient and family member reactions to biomarker-informed Alzheimer’s disease and related disorders diagnoses.
The grant, which is expected to total $3.5 million over up to five years, will enable researchers to better understand the experiences and potential psychological impact of receiving Alzheimer’s biomarker results. These findings will provide important information for supporting patients and their families and inform best practices in the rapidly evolving state-of-the-art diagnostic evaluation of cognitive impairment.
Alzheimer’s disease biomarkers provide important information for patients and families about the causes of cognitive symptoms and, since 2021, can be used to indicate appropriate treatments. Yet, clinicians and researchers lack critical information about the use of these powerful diagnostic tools.
While some patients may expect and even be relieved by diagnostic information, others may experience sustained distress. There are significant gaps in knowledge of the psychological and social impact of delivering Alzheimer’s biomarker information to patients and their families, and the few available data come from samples that are not representative of the general population, including people who consistently lack a history of depression and anxiety, are highly educated, were seen at academic research hospitals and were predominantly non-Hispanic white.
To address this gap, Jennifer Lingler, Ph.D., professor at Pitt’s School of Nursing, and Joshua Grill, Ph.D., professor of psychiatry and human behavior at UCI, are launching the PARADE (Patient and Family Member Reactions to Biomarker-Informed Alzheimer’s Disease and Related Dementias Diagnoses) in cooperation with the New IDEAS study and the Alzheimer’s Association’s TrialMatch® program.
PARADE will leverage data from New IDEAS, a landmark study of Alzheimer’s biomarkers in a diverse population, to enroll a representative real-world population of 500 patients with memory impairment and their family members.
“We are very excited that Drs. Lingler and Grill have received funding from the NIH to complete this work,” said Gil Rabinovici, M.D., professor of memory and aging at the University of California, San Francisco and principal investigator of New IDEAS. “We are confident that it will add an important focus on the patient and family experience and tremendous value to the New IDEAS study.”
END
Pitt and UCI researchers receive grant to understand patient reactions to Alzheimer's disease diagnoses
2023-03-03
ELSE PRESS RELEASES FROM THIS DATE:
Oncotarget | Unveiling the non-canonical functions of EZH2 in prostate cancer
2023-03-03
“In summary, both articles by Yi et al. emphasized the significance of non-canonical functions of EZH2 during PCa [prostate cancer] development [...]”
BUFFALO, NY- March 3, 2023 – A new editorial paper was published in Oncotarget's Volume 14 on February 11, 2023, entitled, “Unveiling the non-canonical functions of EZH2 in prostate cancer.”
Prostate cancer (PCa) is ranked as the second leading cause of cancer-related death among American men excluding skin cancer. ...
Adding antipsychotic med to antidepressant may help older adults with treatment-resistant depression
2023-03-03
For older adults with clinical depression that has not responded to standard treatments, adding the drug aripiprazole (brand name Abilify) to an antidepressant they’re already taking is more effective than switching from one antidepressant to another, according to a new multicenter study led by Washington University School of Medicine in St. Louis.
Aripiprazole originally was approved by the FDA in 2002 as a treatment for schizophrenia but also has been used in lower doses as an add-on treatment for clinical depression ...
American Foregut Society white paper recommends expanding endoscopic classification of esophogastric junction integrity beyond hill grade
2023-03-03
A new white paper by the American Foregut Society recommends expanding the classification of the esophagogastric junction (EGJ) to increase an assessment of the axial hiatal hernia length, hiatal hernia aperture diameter, and presence or absence of the flap value making it more comprehensive. The white paper is published in the December issue of Foregut, the only subscription journal focused exclusively on foregut disease linking medical, endoscopic, and surgical disciplines.
Gastrointestinal reflux disease ...
A good night’s sleep may make it easier to stick to exercise and diet goals, study found
2023-03-03
Research Highlights:
People who had higher scores for sleep health — based on regularity, satisfaction, alertness, timing, efficiency and duration — during a 12-month weight loss program were more likely to follow the caloric intake and exercise components of the program in comparison to peers who scored lower for sleep health.
People with better sleep health attended more of the program’s group sessions.
Embargoed until 10:15 a.m. CT/11:15 a.m. ET, Friday, March 3, 2023
DALLAS, March 3, 2023 — ...
Grant fuels project to highlight untold history across Appalachia
2023-03-03
From working with Appalachian communities to examining issues of displacement for refugees, two Virginia Tech faculty have made it their life and scholarly mission to recognize the people that society often overlooks.
Now a prestigious national foundation is giving them significant resources to tell the hidden historical stories of communities throughout Southwest Virginia, an opportunity to put their passion into action.
Emily Satterwhite and Katrina Powell received a $3 million grant from the Andrew W. Mellon Foundation for a three-year project to work with communities across the state’s Appalachia region to commemorate neglected histories.
Their project, Monuments ...
Augmenting the human body with a wearable robotic arm
2023-03-03
Washington, AAAS Annual Meeting. Imagine having a third arm – a robotic one – to assist you with daily living. Silvestro Micera from EPFL, Switzerland, is engineering the human nervous system to make this a possibility.
For decades, professor Silvestro Micera of EPFL has dedicated his research to helping people with sensory and motor deficits to re-gain independence and quality of life by developing wearable and implantable technologies. But this is changing, as he begins to explore what it means to augment the human body.
The neuroengineer has thus far avoided the subject of ...
Developing individualized, optimized brain injury rehabilitation
2023-03-03
More than 500,000 people in the United States undergo rehabilitation following a stroke or brain injury every year. Movement impairments following a stroke are a major cause of adult disability in the United States, and routine treatments are not currently optimized for individual patient needs.
University of Oklahoma biomedical engineer Yuan Yang, Ph.D., has received a Faculty Early Career Development Award, known as a CAREER award, from the National Science Foundation to advance the scientific study of brain functional changes after a stroke and pioneer a tailored rehabilitation strategy that fits individual needs.
“The way a stroke victim’s brain adapts to the ...
New research highlights importance of meeting caregivers’ needs
2023-03-03
Helping caregivers take better care of themselves can improve the quality of care they provide to individuals with neurological disabilities, according to experts writing in NeuroRehabilitation
Amsterdam, March 3, 2023 – Research on caregiving after neurotrauma and neurological disability extends the focus beyond individuals with neurological conditions to caregivers - family, friends, and significant others who also are also greatly impacted. In this thematic issue published in NeuroRehabilitation, noted experts present the latest research ...
American College of Cardiology honors women’s heart disease pioneer
2023-03-03
Noel Bairey Merz, MD, professor of cardiology and the director of the Barbra Streisand Women’s Heart Center in the Smidt Heart Institute, will receive the 2023 Master of the ACC Award from the American College of Cardiology (ACC) in honor of her pioneering contributions to the cardiovascular profession.
She will be recognized during the ACC’s Annual Scientific Session on Monday, March 6, in New Orleans.
The Master of the ACC Award recognizes and honors ACC Fellows who have served with distinction, consistently contributing to the goals and programs ...
New insights: Eye damage in Alzheimer's disease patients
2023-03-03
Cedars-Sinai investigators have produced the most extensive analysis to date of changes in the retina—a layer of tissue at the back of the eye where visual information originates—and how those retinal changes correspond to brain and cognitive changes in Alzheimer’s disease patients.
Their analysis, published in the peer-reviewed journal Acta Neuropathologica, is an important step toward understanding the complex effects of Alzheimer’s disease on the retina, especially at the earliest stages of cognitive impairment. Experts believe this understanding is key for the development of more effective treatments that could prevent ...